Latest News
Feature
Popular Weight Loss Drugs Now for Patients With Cancer?
Research suggests that obesity can reduce the effectiveness of cancer therapies.
News from the FDA/CDC
FDA Panel Votes for Limits on Gastric, Esophageal Cancer Immunotherapy
The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted in favor of restricting the use of these immunotherapy agents to patients with PD-L1...
Conference Coverage
Myeloma: Daratumumab Plus Lenalidomide Improves MRD Outcomes
New research shows that adding daratumumab to maintenance therapy improves MRD and PFS outcomes in multiple myeloma.
Latest News
Ferritin Cutoff Values Affect Diagnosis of Iron Deficiency
Ferritin cutoff values of 15, 30, and 45 ng/mL were associated with incidences of iron deficiency diagnoses of 10.9, 29.9, and 48.3 cases per 1000...
From the Journals
Minimal Risks With SBRT in Stage I NSCLC
Researchers explored toxicity and 90-day mortality outcomes in patients who received SBRT.
For Residents
First Hike of Medicare Funding for Residencies in 25 Years Aims to Help Shortages
Residency program directors say a recent hike in Medicare funding will help reduce physician shortages and meet growing healthcare needs,...
News from the FDA/CDC
FDA Okays Osimertinib After CRT in Locally Advanced, Unresectable NSCLC
The drug was approved for patients whose disease has not progressed during or after concurrent or sequential platinum-based chemoradiation therapy...
Latest News
Nearly 1 in 3 US Adults May Have Low Iron Levels
Besides anemia, iron deficiency is linked to other serious health problems, including restless legs syndrome, mental and thinking difficulties,...
Conference Coverage
Sex and Gender Influence Outcomes in Colorectal Cancer
Sex differences have clear biological and pathophysiological consequences in oncology.
Feature
Dr. Rogers’ Neighborhood: Guinea Pigs and Groundbreaking Cancer Care
Ohio State leukemia researcher prioritizes patients’ quality of life -- with a little help from her pets.
From the Journals
Survival Outcomes in Hepatocellular Carcinoma Patients Show Improvement Over Time
Researchers conducted a retrospective cohort study to evaluate survival trends among 3441 patients with HCC.